Evommune, Inc. Common Stock (EVMN)

Capital Expenditure

-$183.00K

Quarterly · Period ending: · USD

EVMN logo

EVMN Capital Expenditure

Latest reported-$183.00K
EVMN Quarterly CapEx (-$70.00K → -$183.00K)
High-resolution chart · PNG

EVMN capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-183,000
-83,000
-104,000
-131,000
0
0
0
0
-18,000
-70,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.